United States Últimas notícias

SuperX AI Technology (NASDAQ:SUPX) announced that subsidiary SuperX Microinference signed a long-term equipment and services supply agreement with Australian compute provider Ezisight for 128 B300 AI server clusters.

Former Philadelphia Federal Reserve President Patrick Harker says there are three main issues Fed Chairman Kevin Warsh faces during his first speech at the Jackson Hole Economic Policy Symposium. Harker explains what he's looking to hear from Warsh and why the central bank needs to raise the Fed Funds Rate. He speaks on "Bloomberg Surveillance."

Best Buy (NYSE:BBY) announced that its Board of Directors authorized a regular quarterly cash dividend of $0.96 per common share, with payment scheduled for October 8, 2026.

"There is something shifting in the inflation picture in the US right now," says Claudia Sahm, chief economist at New Century Advisors. She says on "Bloomberg Surveillance" that it would be "most appropriate" for the Federal Reserve to start raising rates.

Chagee Holdings (NASDAQ:CHA) reported second-quarter 2026 net revenue of RMB3,414.6 million (US$503.3 million), up 2.5% year over year from RMB3,331.9 million.

Gap (NYSE:GAP) lowered its full-year 2026 net sales growth forecast after Old Navy reported weaker-than-expected second-quarter results, with company revenue declining 2% to $3.65 billion.

Sitara Sundar, JPMorgan Private Bank Head of Alternate Investment Strategy, joins Bloomberg's Vonnie Quinn on "Bloomberg Brief" to discuss what markets are looking for from Federal Reserve Chair Kevin Warsh's speech at Jackson Hole.

United Therapeutics (NASDAQ:UTHR) announced eight presentations at the 2026 European Society of Cardiology and European Respiratory Society congresses covering investigational therapies for pulmonary arterial hypertension and other lung diseases.

Peter Tchir, head of macro strategy at Academy Securities, says of the US Treasury market, "I don't think this is a bond vigilante thing, I think it's supply and demand," ahead of Federal Reserve Chairman Kevin Warsh's first speech at the Jackson Hole Economic Policy Symposium.

iBio (NASDAQ:IBIO) reported fiscal 2026 results as it advanced into clinical-stage development, with its Phase 1 trial of IBIO-600 progressing after 31 of 32 participants were dosed across four cohorts.

Eli Lilly (NYSE:LLY) received U.S. FDA approval for an expanded indication of Mounjaro (tirzepatide) to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes at high cardiovascular risk.

Altria Group (NYSE:MO) appointed Steven W. Presley to its Board of Directors effective August 27, 2026, adding a director with experience in food and beverage operations.